2003•Qilu yixue zazhiRequires access

EFFECTS OF LIGUSTRAZINE ON EARLY DIABETIC NEPHROPATHY

Xihua Wang

Open publisher page 0 citations

Abstract

Objective To observe the effects of Ligustrazine on early diabetic nephropathy(DN). Methods Sixty-two patients with early DN were randomly divided into control group (31 cases ,regular therapy) and treated group (31 cases ,regular therapy plus Ligustrazine). The course of treatment was 4 weeks. The glomerular filtration rate (GFR),urinary albumin excretion rate(UAER),blood and urine β 2-microglobulin(β 2-MG) were determined for both groups before and after the treatment, the side effects during the treatment were observed as well. Results Blood sugar, GFR, UAER, blood and urine β 2-MG were improved very much for the both groups after the treatment (t=2.917-5.126, P0.05), but the treated group was much better than that of the control group in terms of GFR, UAER and blood β 2-MG (t=2.105-2.864, P0.05). No obvious side effects were found by using Ligustrazine during the treatment. Conclusion Ligustrazine has a beneficial effect on early diabetic nephropathy.

About this research paper

What this paper is about

Objective To observe the effects of Ligustrazine on early diabetic nephropathy(DN). Methods Sixty-two patients with early DN were randomly divided into control group (31 cases ,regular therapy) and treated group (31 cases ,regular therapy plus Ligustrazine). The course of treatment was 4 weeks. The glomerular filtration rate (GFR),urinary albumin excretion rate(UAER),blood and urine β 2-microglobulin(β 2-MG) were determined for both groups before and after the treatment, the side effects during the treatment were observed as well. Results Blood sugar, GFR, UAER, blood and urine β 2-MG were improved very much for the both groups after the treatment (t=2.917-5.126, P0.05), but the treated group was much better than that of the control group in terms of GFR, UAER and blood β 2-MG (t=2.105-2.864, P0.05). No obvious side effects were found by using Ligustrazine during the treatment. Conclusion Ligustrazine has a beneficial effect on early diabetic nephropathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of Ligustrazine on early diabetic nephropathy(DN). Methods Sixty-two patients with early DN were randomly divided into control group (31 cases ,regular therapy) and treated group (31 cases ,regular therapy plus Ligustrazine). The course of treatment was 4 weeks. The glomerular filtration rate (GFR),urinary albumin excretion rate(UAER),blood and urine β 2-microglobulin(β 2-MG) were determined for both groups before and after the treatment, the side effects during the treatment were observed as well. Results Blood sugar, GFR, UAER, blood and urine β 2-MG were improved very much for the both groups after the treatment (t=2.917-5.126, P0.05), but the treated group was much better than that of the control group in terms of GFR, UAER and blood β 2-MG (t=2.105-2.864, P0.05). No obvious side effects were found by using Ligustrazine during the treatment. Conclusion Ligustrazine has a beneficial effect on early diabetic nephropathy.

Key concepts: Medicine, Diabetic nephropathy, Renal function, Urology, Excretion, Urine, Internal medicine, Beta-2 microglobulin

Related papers

Back to paper searchBrowse research topicsOriginal source
EFFECTS OF LIGUSTRAZINE ON EARLY DIABETIC NEPHROPATHY — Research Paper | ScholarLens